Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Pharmacology,General Medicine
Reference23 articles.
1. Handelsman DJ (2013) Global trends in testosterone prescribing, 2000–2011: expanding the spectrum of prescription drug misuse. Med J Aust 199:548–551. https://doi.org/10.5694/mja13.10111
2. Rao PK, Boulet SL, Mehta A, Hotaling J, Eisenberg ML, Honig SC et al (2017) Trends in testosterone replacement therapy use from 2003 to 2013 among reproductive-age men in the United States. J Urol 197:1121–1126. https://doi.org/10.1016/j.juro.2016.10.063
3. Research CFDEA (2019) FDA Drug Safety Communication: FDA cautions about using testosterone products for low testosterone due to aging; requires labeling change to inform of possible increased risk of heart attack and stroke with use. FDA
4. Chase C (2014) The risk of cardiovascular events in men receiving testosterone therapy. An Endocrine Society statement, Endocrine Society
5. Everhart A, Harper K, Jeffery MM, Levin Z, Morden NE, Sankar A et al (2021) Trends in testosterone prescriptions for older men enrolled in commercial insurance and medicare advantage. JAMA Netw Open 4:e2127349–e2127349. https://doi.org/10.1001/jamanetworkopen.2021.27349
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献